Details for New Drug Application (NDA): 216338
✉ Email this page to a colleague
The generic ingredient in PACLITAXEL is paclitaxel. There are sixty-nine drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the paclitaxel profile page.
Summary for 216338
Tradename: | PACLITAXEL |
Applicant: | Teva Pharms Inc |
Ingredient: | paclitaxel |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 216338
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 100MG/VIAL | ||||
Approval Date: | May 11, 2023 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription